Seismic Rumbles Into Clinic With $121m For Novel Immunology Biologics
Series B Cash Will Advance Two Lead Programs
Executive Summary
Less than two years after its $101m series A round, Seismic’s machine-learning powered IMPACT platform for biologics drug discovery yielded two clinical trial-ready assets worthy of a $121m series B.